Northland downgraded Evolv (EVLV) to Market Perform from Outperform with no price target after the company announced the need to restate financial statements given likely early recognition of $4-$6M in revenue. The press release also noted a board committee has found misconduct by certain employees and is investigating when senior personnel became aware of the issue, notes the firm, which is concerned that “these events can become more protracted and messy than expected” and is downgrading the stock until completion of the investigation and restatements.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVLV:
- Evolv delays Q3 release, says certain prior financials shouldn’t be relied upon
- Evolv selloff on filing delay a buying opportunity, says Craig-Hallum
- Evolv sinks 42% on filing delay, Craig-Hallum says ‘too aggressive’
- Evolv falls 42% after delaying Q3 report, saying board conducting investigation
- Evolv Technologies Delays Quarterly Report Amid Investigation